Health
Delay in surgery for prostate cancer does not affect curability
NEWS IN BRIEF — Posted March 20, 2006
Delaying surgery for patients with small, low-grade prostate cancer does not appear to increase the risk of the disease progressing to an incurable form, according to a 10-year-study published in the March 1 Journal of the National Cancer Institute.
Researchers found the risk of incurable prostate cancer, which was defined as a less than 75% chance of remaining disease-free 10 years after surgery, was the same for men receiving immediate surgical treatment and those who waited, on average, two years before surgery.
"This study suggests that for carefully selected men with prostate cancer who are monitored, the window of cure does not close in the short term," said H. Ballentine Carter, MD, lead author of the study and a professor of urology at the Johns Hopkins School of Medicine in Baltimore.
"For those men diagnosed with early-stage, low-grade prostate cancer, an alternative to immediate surgical treatment would be careful surveillance," Dr. Carter said.
Note: This item originally appeared at http://www.ama-assn.org/amednews/2006/03/20/hlbf0320.htm.












